BAILLAT D., A. BÈGUE, D. STÉHELIN and M. AUMERCIER.
ETS-1 transcription factor binds cooperatively to the palindromic head to head ETS binding sites of the stromelysin-1 promoter by counteracting auto-inhibition.
Journal of Biological Chemistry (2002), vol. 277, pp. 29386-29398.

 NGOHANG-NDONG J., D. BAILLAT, M. AUMERCIER, F. BELLEFONTAINE, G. S. BESRA, C. LOCHT and A. BAULARD.
EthR, a repressor of the TetR/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator.
Molecular Microbiology (2004), vol 51, pp. 175-188.

 LEPRIVIER G., D. BAILLAT, T. MALLIAVIN, A. BÈGUE, B. HARTMANN and M. AUMERCIER
DNA bending as a determinant of the differential binding stoichiometry of the human isoforms of Ets-1, p51 and p42, on the palindromic Ets binding sites of the stromelysin-1 promoter
The FEBS Journal (2005), vol. 272, Supplement 1, pp. 478.

 BAILLAT D., G. LEPRIVIER, D. RÉGNIER, N. VINTONENKO, A. BÈGUE, D. STÉHELIN. and M. AUMERCIER.
Stromelysin-1 expression is activated in vivo by Ets-1 factor through palindromic head to head Ets binding sites present in the promoter.
Oncogene (2006), vol. 25, pp. 5764-5776.

 LAITEM C., G. LEPRIVIER and M. AUMERCIER.
Characterization of Ets-1 p27, a novel isoform of Ets-1 oncoprotein.
The FEBS Journal (2008), vol. 275, Supplement 1, pp. 454.

 LAITEM C., S. CHOUL-LI, D. BAILLAT, A. BÈGUE and M. AUMERCIER.
Efficient system for biotinylated recombinant Ets-1 production in Escherichia coli : a useful tool for studying interactions between Ets-1 and its partners.
Protein Expression and Purification (2008), vol. 62, pp. 53-63.

 AUMERCIER M.
Stromelysin-1.
In : Enyclopedia of Cancer (2009), 2nd Edition, Springer-Verlag, Heidelberg, Editor Dr. Manfred Schwab, vol.4, pp.2845-2849.

 BAILLAT D., C. LAITEM, G. LEPRIVIER, C. MARGERIN and M. AUMERCIER.
Ets-1 binds cooperatively to the palindromic Ets-binding sites in the p53 promoter.
Biochemical and Biophysical Research Communications (2009), vol. 378, pp. 213- 217.

 LÖSSNER D., C. ABOU-AJRAM, A. BENGE, M. AUMERCIER, M. SCHMITT and U. REUNING.
Integrin ανβ3 upregulates integrin-linked kinase expression in human ovarian cancer cells via enhancement of ILK gene transcription.
Journal of Cellular Physiology (2009), vol. 220, pp. 367-375.

 WILLAND N., B. DIRIÉ, X. CARETTE, P. BIFANI, A. SINGHAL, M. DESROSES, F. LEROUX, E. WILLERY, V. MATHYS, R. DÉPREZ-POULAIN, G. DELCROIX, F. FRENOIS, M. AUMERCIER, C. LOCHT, V. VILLERET, B. DÉPREZ and A. R. BAULARD.
Synthetic EthR inhibitors boost antituberculous activity of ethionamide.
Nature Medicine (2009), vol. 15, pp. 537-544.

 LAITEM C., G. LEPRIVIER, S. CHOUL-LI, A. BÈGUE, D. MONTE, P. DUMONT, D. LARSIMONT, M. DUTERQUE-COQUILLAUD and M AUMERCIER.
Ets-1 p27 : a novel Ets-1 isoform with dominant negative effects on the transcriptional properties and the subcellular localization of Ets-1 p51.
Oncogene (2009), vol. 28, pp. 2087-2099.

 LEPRIVIER G., D. BAILLAT, A. BÈGUE, B. HARTMANN and M. AUMERCIER.
Ets-1 p51 and p42 isoforms differentially modulate Stromelysin-1 promoter via DNA bend orientation.
Nucleic Acids Research (2009), vol. 37, pp. 4341-4352.

 CHOUL-LI S., C. LAITEM, I. ROLAND, H. DROBECQ and M. AUMERCIER.
DNA-PK and PARP-1, novel interaction partners of Ets-1 transcription factor.
The FEBS Journal (2009), vol. 276, Supplement 1, pp. 370.

 CHOUL-LI S., H. DROBECQ and M. AUMERCIER.
DNA-dependent protein kinase is a novel interaction partner for Ets-1 isoforms.
Biochemical and Biophysical Research Communications (2009), vol. 390, pp. 839- 844.

 CHOUL-LI S., C. LEROY, G. LEPRIVIER, C. LAITEM, D. TULASNE and M.  AUMERCIER.
Caspase cleavage of Ets-1 p51 generates fragments with transcriptional dominant- negative function.
Biochemical Journal (2010), vol. 426, pp. 229-241.

Retour